The Global Primary Aldosteronism Market is segmented on the basis of type, indications, diagnosis, treatment and end users. On the basis of type, the market is segmented as Type I, and Type II. On the basis of indications, the market is categorized into heart attack, kidney failure, stroke, and others. On the basis of diagnosis, the market is segmented into blood test, imaging, and others. The blood test segment is sub-segmented into aldosterone profiling, renin profiling, and others. The imaging segment is sub-segmented into computed tomography (CT), positron emission tomography (PET), and others.

On the basis of end users, the market is segmented into surgery, aldosterone antagonists, and others. The aldosterone antagonists are sub-m segmented into spironolactone, eplerenone, and others.

Primary Aldosteronism Market Regional Analysis:

America dominates the global primary aldosteronism market owing to a well-developed healthcare sector and a huge patient population. Apart from this, changing lifestyle and increasing healthcare expenditure have boosted the growth of the market in America. According to the Population Reference Bureau, the American geriatric population is projected to double and reach approximately over 98 million by 2060.

Europe is the second largest market for primary aldosteronism ,and is followed by Asia Pacific. Availability of funds for research, a huge patient population and government support for research & development are the driving factors for the market within the region. On a regional basis, the market is segmented into Western Europe, and Eastern Europe. The Western Europe leads the market due to the presence of developed economies like Germany, Italy, France, and others. On the other hand, Eastern Europe is estimated to be the fastest growing market.

Asia Pacific is projected to be the fastest growing region for the market due to the presence of a huge patient population, continuously developing economies like India and China. According to the Indian Brand Equity Foundation, the Indian healthcare sector is estimated to be one of the fastest growing sectors and is projected to advance at an estimated CAGR of 22.87% from 2015 to 2020 and reach USD 280 billion till 2020.

On the other hand, the Middle East & Africa has the least share in the global primary aldosteronism market due to the presence of weak economies, stringent government policies and lack of healthcare services especially within the African region. A majority of the market within the Middle East and Africa is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure in the region.

The key players for the global primary aldosteronism market are Pfizer Inc. (U.S.), Sun Pharmaceutical Industries Ltd.  (India), Bristol Laboratories Ltd (England), CMP Pharma. (U.S.), Koninklijke Philips N.V. (The Netherlands), GE Healthcare (U.K), Siemens AG (Germany), Shimadzu Corporation (Japan), Canon Inc. (Japan), and others.

Primary Aldosteronism Market Segmentation:

The global primary aldosteronism market is segmented on the basis of type, indications, diagnosis, treatment and end users.

On the basis of type, the market is segmented as Type I, and Type II. On the basis of indications, the market is categorized into heart attack, kidney failure, stroke, and others. On the basis of diagnosis, the market is segmented into blood test, imaging, and others. The blood test segment is sub-segmented into aldosterone profiling, renin profiling, and others. The imaging segment is sub-segmented into computed tomography (CT), positron emission tomography (PET), and others.On the basis of end users, the market is segmented into surgery, aldosterone antagonists, and others. The aldosterone antagonists are sub-m segmented into spironolactone, eplerenone, and others.

Primary Aldosteronism Market research report, Type (type I, type II), Indication (heart attack, kidney failure, stroke), by Diagnosis (blood test, imaging), Treatment (surgery, aldosterone antagonists), End User (hospitals) - Global forecast till 2023 @ https://www.marketresearchfuture.com/sample_request/5522 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: [email protected]